12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. NexImmune (NEXI) saw a dramatic increase of 540.4%, while Generation Bio (GBIO) and Altimmune (ALT) also posted substantial gains. Conversely, Ampio Pharmaceuticals (AMPE) and Intelligent Bio Solutions (INBS) were among the biggest losers, with sharp declines in their stock prices.

December 01, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ampio Pharmaceuticals' shares plummeted by 42.7% to $3.3, with a market cap of $2.7 million.
The sharp decline in Ampio Pharmaceuticals' stock price suggests a strong negative market reaction, possibly due to disappointing company news or performance, which could continue to pressure the stock in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Intelligent Bio Solutions' stock fell by 28.46% to $0.3, with a market cap of $2.6 million.
Intelligent Bio Solutions' significant stock price drop indicates negative sentiment that could persist in the short term, affecting investor confidence.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Altimmune's shares rose by 28.48% to $4.06, with a market cap of $218.1 million.
Altimmune's notable stock price increase could attract more investors, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Generation Bio shares increased by 31.81% to $1.49, with a market cap of $98.4 million.
The significant rise in Generation Bio's stock price suggests positive investor sentiment, which may result in continued short-term upward momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
NexImmune's stock soared by 540.4% to $11.07, with a market cap of $11.7 million.
The extraordinary rise in NexImmune's stock price indicates a highly positive market reaction, likely due to significant company news or breakthroughs, which could continue to drive investor interest in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100